Deleting all antimicrobial peptide genes in fruit flies shortened lifespan not through direct aging effects, but because the flies could no longer control gut bacteria, and germ-free conditions rescued their lifespan.
Lifespan fully rescuedwhen AMP-deficient flies were raised germ-free, proving reduced lifespan was due to microbiome dysbiosis, not direct aging effects
What the researchers found
Using isogenic AMP gene deletions in Drosophila, no individual antimicrobial peptide had a major effect on lifespan, with the possible exception of Defensin. However, ΔAMP14 flies lacking seven AMP gene families showed significantly reduced lifespan.
The lifespan reduction was traced to microbiome dysbiosis: aged ΔAMP14 flies had increased bacterial loads in their food. Critically, raising ΔAMP14 flies under germ-free conditions restored their lifespan, proving the reduced lifespan was due to loss of microbial control, not a direct role of AMPs in aging or inflammation.
Why it matters
AMPs increase with age in many organisms, fueling the hypothesis that they drive age-related inflammatory diseases ('inflammaging'). This study overturns that narrative by showing AMPs are not causing aging — they're fighting it by keeping gut bacteria under control. This reframes how we think about immune peptides in aging and highlights the importance of maintaining antimicrobial defenses throughout life.
How the study worked
The researchers created an isogenic set of Drosophila with deletions in individual AMP genes and a comprehensive ΔAMP14 line lacking seven AMP gene families. They measured lifespan in conventional and germ-free conditions, assessed bacterial loads in aged flies' food, and compared the effects of individual versus collective AMP loss on longevity.
What this study cannot tell us
The study was conducted in Drosophila, and the findings may not directly translate to mammalian aging. The microbiome of fruit flies is simpler than the human gut microbiome. The study focused on lifespan as the primary outcome and did not extensively characterize other age-related phenotypes. The possible exception of Defensin's individual effect needs further investigation.
How to read the evidence
This is a well-designed preclinical study using isogenic gene deletions in Drosophila with multiple controls including germ-free conditions. It provides strong mechanistic evidence in a model organism but findings need validation in mammals.
When this study was published
Published in 2023 in Disease Models & Mechanisms, this study addresses an active debate in the aging and immunology fields about whether antimicrobial peptides cause or prevent age-related decline.
The bigger picture
This work reframes the role of antimicrobial peptides in aging. Rather than being drivers of harmful age-related inflammation, AMPs appear to be protective against the microbiome dysbiosis that accelerates aging. This has implications for the broader inflammaging field and for understanding why immune function matters for longevity — not just to fight infections, but to maintain the microbial balance that underpins healthy aging.
Questions still open
- Do antimicrobial peptides play a similar protective role against microbiome dysbiosis during aging in mammals?
- Could boosting AMP levels in aged organisms extend lifespan by preventing dysbiosis?
- What is the specific role of Defensin that distinguishes it from other AMPs in lifespan effects?
Common questions
Do antimicrobial peptides cause age-related inflammation?
What does this mean for human aging?
Read the original research
Antimicrobial peptides do not directly contribute to aging in Drosophila, but improve lifespan by preventing dysbiosis.
Disease models & mechanisms, 16(4)
Citation
Hanson, Mark A; Lemaitre, Bruno. (2023). Antimicrobial peptides do not directly contribute to aging in Drosophila, but improve lifespan by preventing dysbiosis.. Disease models & mechanisms, 16(4). https://doi.org/10.1242/dmm.049965